Navigation Links
Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments

INDIANAPOLISThe Human Genome Sequencing Center at Baylor College of Medicine boosted its sequencing capabilities with an agreement to acquire seven additional Genome Sequencer FLX Systems from 454 Life Sciences, a Roche company.

With 10 Genome Sequencer FLX Systems, the Human Genome Sequencing Center will be in a unique position to apply 454 Life Sciences technologies to problems ranging from the deciphering of new genomes to the analysis of mutations associated with human diseases.

These instruments previously proved their capabilities in the arena of whole genome sequencing, said Richard Gibbs, Professor and Director of the Human Genome Sequencing Center at Baylor College of Medicine, a former member of the 454 Life Sciences Scientific Advisory Board until March 2007. Now they have demonstrated their potential role in large scale mutation detection.

To better understand genetic basis for disease - including cancer, heart disease, and asthma - genomic information from large numbers of individuals need to be analyzed in a rapid and cost-effective manner. Rapid DNA sequencing technologies allow researchers to identify all genetic changes when comparing healthy individuals to those with disease.

This purchase helps demonstrate that the GS FLX is a proven technology with nearly 100 published peer-review articles, said Lonnie Shoff, Senior Vice President of Molecular Diagnostics and Applied Science for Roche Diagnostics. We see the GS FLX being used in production sequencing due to the systems scalability to support both small and very large projects, along with the instruments durability, which allows it to be run continuously.

These efforts using the Genome Sequencer FLX are further enhanced by a collaboration with the Human Genome Sequencing Center at Baylor College of Medicine and another Roche company, Roche NimbleGen. Preliminary work from the collaboration was reported in Nature Methods this week, and uses microarrays to capture up to 6,500 human gene parts, or exons, for sequence analysis, reducing the dependence on large-scale polymerase chain reaction.

With this combination of 454 and NimbleGen methods, we have an unprecedented ability to detect changes across the human genome, said Gibbs.

The new Genome Sequencer FLX systems will also be applied to the analysis of bacterial genomes in a National Institutes of Health supported effort to analyze metagenomes collections of bacteria that live in human hosts both normally and in infectious disease.

The GS FLX system has been remarkably successfulnot only for human medical resequencingbut also for microbial genome sequencing. Expanding our sequencing capabilities with the additional systems figures prominently in our plans for the Human Microbiome Project, said George Weinstock, co-Director and leader of its Microbial Genomics Programs for the Human Genome Sequencing Center at Baylor College of Medicine.

In addition to the purchase agreement, the Human Genome Sequencing Center and Roche also expanded their prior collaboration. The center will obtain early access to next generation updates to the Genome Sequencer FLX system. The system improvements will include an increase in sequence read length beyond 400 base pairs. The net result will be a sequencing solution that generates more than 1 billion bases per day. Other updates focus on improvements that make it easier to routinely sequence human genomes. These system improvements include enhancements in the reagents and software, utilizing the same hardware configuration that is currently available and purchased as part of this agreement.


Contact: Lori McLaughlin

Related medicine news :

1. Grant of $7 million for Orissa Medical College from Japan
2. Orissa To Get New Medical Colleges Soon
3. Kottayam Medical College To be Upgraded
4. Kasturba Medical College Organizes CME- Orth 2005 From 4th To 6th November
5. Disadvantaged Students May Not Go In For College Education
6. Medical College Construction At Raichur Makes Slow Progress
7. Risk Attitudes And Consequences Of College Drinking
8. Call Of The Wild: Heard Of Spring Drinking? Ask The College Girls, Who Are Getting Freaked Out
9. Calcutta National Medical College Strike Continues Unabated
10. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
11. Ignorance about AIDS rampart in Third of College Students: Chinese survey
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
Breaking Medicine Technology: